These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 21999627)

  • 1. New alkyl-lipid blockers of SK3 channels reduce cancer cell migration and occurrence of metastasis.
    Girault A; Haelters JP; Potier-Cartereau M; Chantome A; Pinault M; Marionneau-Lambot S; Oullier T; Simon G; Couthon-Gourvès H; Jaffrès PA; Corbel B; Bougnoux P; Joulin V; Vandier C
    Curr Cancer Drug Targets; 2011 Nov; 11(9):1111-25. PubMed ID: 21999627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The SK3/K(Ca)2.3 potassium channel is a new cellular target for edelfosine.
    Potier M; Chantome A; Joulin V; Girault A; Roger S; Besson P; Jourdan ML; LeGuennec JY; Bougnoux P; Vandier C
    Br J Pharmacol; 2011 Jan; 162(2):464-79. PubMed ID: 20955368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Disaccharide-Based Ether Lipids as SK3 Ion Channel Inhibitors.
    Berthe W; Sevrain CM; Chantôme A; Bouchet AM; Gueguinou M; Fourbon Y; Potier-Cartereau M; Haelters JP; Couthon-Gourvès H; Vandier C; Jaffrès PA
    ChemMedChem; 2016 Jul; 11(14):1531-9. PubMed ID: 27278812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting SKCa channels in cancer: potential new therapeutic approaches.
    Girault A; Haelters JP; Potier-Cartereau M; Chantôme A; Jaffrés PA; Bougnoux P; Joulin V; Vandier C
    Curr Med Chem; 2012; 19(5):697-713. PubMed ID: 22204342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of pyrene-based fluorescent ether lipid as inhibitor of SK3 ion channels.
    Bauduin A; Papin M; Chantôme A; Couthon H; Deschamps L; Requejo-Isidro J; Vandier C; Jaffrès PA
    Eur J Med Chem; 2021 Jan; 209():112894. PubMed ID: 33049604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DiGalactosyl-Glycero-Ether Lipid: synthetic approaches and evaluation as SK3 channel inhibitor.
    Sevrain CM; Haelters JP; Chantôme A; Couthon-Gourvès H; Gueguinou M; Potier-Cartereau M; Vandier C; Jaffrès PA
    Org Biomol Chem; 2013 Jul; 11(27):4479-87. PubMed ID: 23715410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The small conductance calcium-activated potassium channel 3 (SK3) is a molecular target for Edelfosine to reduce the invasive potential of urothelial carcinoma cells.
    Steinestel K; Eder S; Ehinger K; Schneider J; Genze F; Winkler E; Wardelmann E; Schrader AJ; Steinestel J
    Tumour Biol; 2016 May; 37(5):6275-83. PubMed ID: 26619845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SK3/TRPC1/Orai1 complex regulates SOCE-dependent colon cancer cell migration: a novel opportunity to modulate anti-EGFR mAb action by the alkyl-lipid Ohmline.
    Guéguinou M; Harnois T; Crottes D; Uguen A; Deliot N; Gambade A; Chantôme A; Haelters JP; Jaffrès PA; Jourdan ML; Weber G; Soriani O; Bougnoux P; Mignen O; Bourmeyster N; Constantin B; Lecomte T; Vandier C; Potier-Cartereau M
    Oncotarget; 2016 Jun; 7(24):36168-36184. PubMed ID: 27102434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophysiological characterization of the SK channel blockers methyl-laudanosine and methyl-noscapine in cell lines and rat brain slices.
    Scuvée-Moreau J; Boland A; Graulich A; Van Overmeire L; D'hoedt D; Graulich-Lorge F; Thomas E; Abras A; Stocker M; Liégeois JF; Seutin V
    Br J Pharmacol; 2004 Nov; 143(6):753-64. PubMed ID: 15504758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SK3-1C, a dominant-negative suppressor of SKCa and IKCa channels.
    Kolski-Andreaco A; Tomita H; Shakkottai VG; Gutman GA; Cahalan MD; Gargus JJ; Chandy KG
    J Biol Chem; 2004 Feb; 279(8):6893-904. PubMed ID: 14638680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thio-ether functionalized glycolipid amphiphilic compounds reveal a potent activator of SK3 channel with vasorelaxation effect.
    Sevrain CM; Fontaine D; Bauduin A; Guéguinou M; Zhang BL; Chantôme A; Mahéo K; Pasqualin C; Maupoil V; Couthon H; Vandier C; Jaffrès PA
    Org Biomol Chem; 2021 Mar; 19(12):2753-2766. PubMed ID: 33687423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pivotal role of the lipid Raft SK3-Orai1 complex in human cancer cell migration and bone metastases.
    Chantôme A; Potier-Cartereau M; Clarysse L; Fromont G; Marionneau-Lambot S; Guéguinou M; Pagès JC; Collin C; Oullier T; Girault A; Arbion F; Haelters JP; Jaffrès PA; Pinault M; Besson P; Joulin V; Bougnoux P; Vandier C
    Cancer Res; 2013 Aug; 73(15):4852-61. PubMed ID: 23774210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alkyl ether lipids, ion channels and lipid raft reorganization in cancer therapy.
    Jaffrès PA; Gajate C; Bouchet AM; Couthon-Gourvès H; Chantôme A; Potier-Cartereau M; Besson P; Bougnoux P; Mollinedo F; Vandier C
    Pharmacol Ther; 2016 Sep; 165():114-31. PubMed ID: 27288726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of the small-conductance, calcium-activated potassium channel SK3 is critical for pacemaker control in dopaminergic midbrain neurons.
    Wolfart J; Neuhoff H; Franz O; Roeper J
    J Neurosci; 2001 May; 21(10):3443-56. PubMed ID: 11331374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of SK3 channel as a new mediator of breast cancer cell migration.
    Potier M; Joulin V; Roger S; Besson P; Jourdan ML; Leguennec JY; Bougnoux P; Vandier C
    Mol Cancer Ther; 2006 Nov; 5(11):2946-53. PubMed ID: 17121942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic coupling between TRPV4 and Ca
    Li Y; Hu H; Tian JB; Zhu MX; O'Neil RG
    Am J Physiol Renal Physiol; 2017 Jun; 312(6):F1081-F1089. PubMed ID: 28274924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antidepressant fluoxetine blocks the human small conductance calcium-activated potassium channels SK1, SK2 and SK3.
    Terstappen GC; Pellacani A; Aldegheri L; Graziani F; Carignani C; Pula G; Virginio C
    Neurosci Lett; 2003 Jul; 346(1-2):85-8. PubMed ID: 12850554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective positive modulation of the SK3 and SK2 subtypes of small conductance Ca2+-activated K+ channels.
    Hougaard C; Eriksen BL; Jørgensen S; Johansen TH; Dyhring T; Madsen LS; Strøbaek D; Christophersen P
    Br J Pharmacol; 2007 Jul; 151(5):655-65. PubMed ID: 17486140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identity and function of a cardiac mitochondrial small conductance Ca
    Yang M; Camara AKS; Aldakkak M; Kwok WM; Stowe DF
    Biochim Biophys Acta Bioenerg; 2017 Jun; 1858(6):442-458. PubMed ID: 28342809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The SK3 subunit of small conductance Ca2+-activated K+ channels interacts with both SK1 and SK2 subunits in a heterologous expression system.
    Monaghan AS; Benton DC; Bahia PK; Hosseini R; Shah YA; Haylett DG; Moss GW
    J Biol Chem; 2004 Jan; 279(2):1003-9. PubMed ID: 14559917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.